GS-441524: Your Trusted Supplier for a Key Remdesivir Metabolite and FIPV Inhibitor

Discover high-purity GS-441524, a critical metabolite of Remdesivir and a potent inhibitor for Feline Infectious Peritonitis Virus (FIPV). Essential for antiviral research and pharmaceutical intermediate synthesis, we are your reliable manufacturer and supplier in China, offering competitive pricing and timely delivery.

Get a Quote & Sample

Key Advantages of Sourcing GS-441524 from Us

Exceptional Purity and Quality

Our GS-441524 is manufactured to stringent quality standards, ensuring 97% minimum purity, making it suitable for critical pharmaceutical research and development. Trust us as your go-to manufacturer for reliable intermediates.

Broad Antiviral Spectrum Research

GS-441524 is instrumental in studying antiviral mechanisms, particularly its potent inhibitory effect against Feline Infectious Peritonitis Virus (FIPV) with an EC50 of 0.78 µM. It's also the active metabolite of Remdesivir, vital for COVID-19 research.

Secure Supply Chain & Competitive Pricing

As a leading supplier in China, we guarantee a stable supply for your procurement needs. We offer competitive prices and efficient logistics, making it easier for you to buy or purchase GS-441524 in bulk.

Diverse Applications for GS-441524 in Research

Antiviral Drug Development

Utilize GS-441524 as a crucial intermediate in the synthesis and research of advanced antiviral drugs, contributing to the fight against infectious diseases.

Feline Infectious Peritonitis (FIP) Research

This compound is essential for scientific studies focusing on FIPV, providing researchers with a key tool to understand and combat this feline disease. Explore how to buy FIPV inhibitors.

Remdesivir Metabolism Studies

Investigate the pharmacokinetic and metabolic pathways of Remdesivir by using GS-441524 as a reference standard. This aids in optimizing drug efficacy and safety.

RNA Virus Research

As a nucleotide analog, GS-441524 is invaluable for exploring the mechanisms of viral RNA replication and developing broad-spectrum antiviral agents.